REG-$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
Nyxoah completed a $95 million equity financing and expects to receive a $15 million tranche from its European Investment Bank loan, totaling $110 million in new capital. The company will use the proceeds to accelerate the U.S. commercial launch of its FDA-approved Genio hypoglossal neurostimulation system for obstructive sleep apnea. The equity raise featured strong insider participation, and the company now has 40 sales representatives in place under a new U.S.
Key figures
- Deal Value Usd
- 110000000
- Us sales reps
- 40
- Debt financing
- 15000000
- Equity financing
- 95000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.